CEO of Surgical Robotics Company Mazor Robotics Subject of Insider Trading Probe
The investigation concerns a May 2016 deal with medical device maker Medtronic
Tomer Ganon and Dror Reich | 17:11 03.12.2017
Ori Hadomi, the CEO of surgical robots company Mazor Robotics Ltd., is under investigation by the Israel Securities Authority concerning insider trading accusations, according to documents reviewed by Calcalist.
For daily updates, subscribe to our newsletter by clicking here .
Founded in 2001, Nasdaq-listed Mazor develops and manufactures robotic guidance systems for brain and spine surgery. In May 2016, the company signed a strategic agreement with medical device maker Medtronic PLC, under which the latter received control of the distribution of Mazor’s spinal surgery systems in the U.S. In September, the two companies announced that Medtronic would assume worldwide control of the distribution of the systems and invest an additional $40 million in Mazor, bringing its overall investment to $74 million.
In reply to a request for comment, a spokesman for Mazor Robotics said the company does not comment out of the scope of its official reports.
More by CTech
Mr. Hadomi's legal representation has yet to respond to a request for comment.
No Comments Add Comment